Janus Henderson Group PLC Arcus Biosciences, Inc. Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 18,038 shares of RCUS stock, worth $297,266. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,038

Previous 18,256 1.19%

Holding current value

$297,266

Previous $344,000 20.35%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$14.59 - $18.48 $3,180 - $4,028	-218 Reduced 1.19%	18,038 $274,000
Q1 2024 May 15, 2024	SELL	$14.83 - $20.18 $444 - $605	-30 Reduced 0.16%	18,256 $344,000
Q4 2023 Feb 14, 2024	SELL	$13.43 - $19.63 $470 - $687	-35 Reduced 0.19%	18,286 $349,000
Q3 2023 Nov 14, 2023	BUY	$17.62 - $23.54 $70 - $94	4 Added 0.02%	18,321 $328,000
Q2 2023 Aug 14, 2023	SELL	$16.97 - $22.03 $407 - $528	-24 Reduced 0.13%	18,317 $372,000
Q1 2023 May 15, 2023	BUY	$15.96 - $23.15 $292,722 - $424,594	18,341 New	18,341 $334,000
Q3 2022 Nov 14, 2022	SELL	$23.23 - $30.07 $2,183 - $2,826	-94 Reduced 1.16%	8,002 $209,000
Q2 2022 Aug 15, 2022	BUY	$17.23 - $37.73 $2,102 - $4,603	122 Added 1.53%	8,096 $205,000
Q1 2022 May 16, 2022	SELL	$28.92 - $41.83 $202 - $292	-7 Reduced 0.09%	7,974 $252,000
Q4 2021 Feb 14, 2022	BUY	$31.38 - $48.47 $250,443 - $386,839	7,981 New	7,981 $323,000
Q1 2020 May 14, 2020	SELL	$8.78 - $19.28 $2.6 Million - $5.71 Million	-296,000 Closed	0 $0
Q4 2019 Feb 18, 2020	SELL	$7.33 - $10.79 $1.5 Million - $2.21 Million	-204,654 Reduced 40.88%	296,000 $2.99 Million
Q3 2019 Nov 14, 2019	SELL	$6.44 - $10.18 $44,275 - $69,987	-6,875 Reduced 1.35%	500,654 $4.56 Million
Q2 2019 Jul 31, 2019	BUY	$7.29 - $13.38 $4,964 - $9,111	681 Added 0.13%	507,529 $4.04 Million
Q1 2019 Apr 30, 2019	SELL	$8.95 - $12.49 $3,499 - $4,883	-391 Reduced 0.08%	506,848 $6.33 Million
Q4 2018 Feb 06, 2019	BUY	$9.74 - $14.5 $359,766 - $535,586	36,937 Added 7.85%	507,239 $5.46 Million
Q3 2018 Nov 09, 2018	BUY	$10.88 - $14.95 $8,562 - $11,765	787 Added 0.17%	470,302 $6.56 Million
Q2 2018 Aug 10, 2018	BUY	$12.24 - $17.05 $11,358 - $15,822	928 Added 0.2%	469,515 $5.75 Million
Q1 2018 May 14, 2018	BUY	$15.44 - $17.71 $7.23 Million - $8.3 Million	468,587 New	468,587 $7.24 Million

Others Institutions Holding RCUS

# of Institutions

207

Shares Held

49M

Call Options Held

173K

Put Options Held

151K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.19B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Arcus Biosciences, Inc. Transaction History